| First Author | Saito M | Year | 2011 |
| Journal | J Biol Chem | Volume | 286 |
| Issue | 44 | Pages | 38602-13 |
| PubMed ID | 21880733 | Mgi Jnum | J:180718 |
| Mgi Id | MGI:5306878 | Doi | 10.1074/jbc.M111.243451 |
| Citation | Saito M, et al. (2011) ADAMTSL6beta protein rescues fibrillin-1 microfibril disorder in a Marfan syndrome mouse model through the promotion of fibrillin-1 assembly. J Biol Chem 286(44):38602-13 |
| abstractText | Marfan syndrome (MFS) is a systemic disorder of the connective tissues caused by insufficient fibrillin-1 microfibril formation and can cause cardiac complications, emphysema, ocular lens dislocation, and severe periodontal disease. ADAMTSL6beta (A disintegrin-like metalloprotease domain with thrombospondin type I motifs-like 6beta) is a microfibril-associated extracellular matrix protein expressed in various connective tissues that has been implicated in fibrillin-1 microfibril assembly. We here report that ADAMTSL6beta plays an essential role in the development and regeneration of connective tissues. ADAMTSL6beta expression rescues microfibril disorder after periodontal ligament injury in an MFS mouse model through the promotion of fibrillin-1 microfibril assembly. In addition, improved fibrillin-1 assembly in MFS mice following the administration of ADAMTSL6beta attenuates the overactivation of TGF-beta signals associated with the increased release of active TGF-beta from disrupted fibrillin-1 microfibrils within periodontal ligaments. Our current data thus demonstrate the essential contribution of ADAMTSL6beta to fibrillin-1 microfibril formation. These findings also suggest a new therapeutic strategy for the treatment of MFS through ADAMTSL6beta-mediated fibrillin-1 microfibril assembly. |
